Research ArticleArticle
Inhibition of Tumor Necrosis Factor-α-Converting Enzyme by a Selective Antagonist Protects Brain from Focal Ischemic Injury in Rats
Xinkang Wang, Giora Z. Feuerstein, Lin Xu, Hugh Wang, William A. Schumacher, Martin L. Ogletree, Rebecca Taub, James J.-W. Duan, Carl P. Decicco and Rui-Qin Liu
Molecular Pharmacology April 2004, 65 (4) 890-896; DOI: https://doi.org/10.1124/mol.65.4.890
Xinkang Wang
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
Giora Z. Feuerstein
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
Lin Xu
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
Hugh Wang
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
William A. Schumacher
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
Martin L. Ogletree
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
Rebecca Taub
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
James J.-W. Duan
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
Carl P. Decicco
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
Rui-Qin Liu
Departments of Thrombosis Research (X.W., G.Z.F., L.X., H.W., W.A.S., M.L.O.), Neurosciences (R.A.T.), Discovery Chemistry (J.D., C.P.D.), and Inflammatory Disease Research (R.L.), Bristol-Myers Squibb Company, Princeton, New Jersey
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Inhibition of Tumor Necrosis Factor-α-Converting Enzyme by a Selective Antagonist Protects Brain from Focal Ischemic Injury in Rats
Xinkang Wang, Giora Z. Feuerstein, Lin Xu, Hugh Wang, William A. Schumacher, Martin L. Ogletree, Rebecca Taub, James J.-W. Duan, Carl P. Decicco and Rui-Qin Liu
Molecular Pharmacology April 1, 2004, 65 (4) 890-896; DOI: https://doi.org/10.1124/mol.65.4.890
Research ArticleArticle
Inhibition of Tumor Necrosis Factor-α-Converting Enzyme by a Selective Antagonist Protects Brain from Focal Ischemic Injury in Rats
Xinkang Wang, Giora Z. Feuerstein, Lin Xu, Hugh Wang, William A. Schumacher, Martin L. Ogletree, Rebecca Taub, James J.-W. Duan, Carl P. Decicco and Rui-Qin Liu
Molecular Pharmacology April 1, 2004, 65 (4) 890-896; DOI: https://doi.org/10.1124/mol.65.4.890
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement